Is low PSA good?

Low PSA levels (under 4.0 ng/mL) are generally good and indicate lower prostate cancer risk, but very low levels don't guarantee prostate health. Regular monitoring is important since PSA can rise with age, and some aggressive cancers may not elevate PSA significantly.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What is PSA and Why Does It Matter?

Prostate-specific antigen (PSA) is a protein produced by cells in the prostate gland, a small walnut-sized organ that sits below the bladder in men. Both normal and cancerous prostate cells produce PSA, which enters the bloodstream in small amounts. Measuring PSA levels through a simple blood test has become one of the primary screening tools for prostate health, particularly for detecting prostate cancer.

PSA testing matters because elevated levels can signal various prostate conditions, from benign prostatic hyperplasia (BPH) to prostatitis or prostate cancer. However, understanding what constitutes a "good" PSA level isn't always straightforward. While high PSA levels often raise red flags, many men wonder whether low PSA levels are universally positive or if there are nuances to consider.

Understanding PSA Level Ranges

PSA levels are measured in nanograms per milliliter (ng/mL) of blood. The traditional reference ranges have evolved over the years as researchers have gained more insight into prostate health. Here's what current medical guidelines suggest about PSA levels:

Age-Adjusted PSA Reference Ranges

These ranges are guidelines. Individual risk factors and PSA velocity should also be considered.
Age RangeNormal PSA Range (ng/mL)Borderline Range (ng/mL)Concerning Level (ng/mL)
40-49 years40-49 years0-2.52.5-3.5>3.5
50-59 years50-59 years0-3.53.5-4.5>4.5
60-69 years60-69 years0-4.54.5-6.5>6.5
70+ years70+ years0-6.56.5-8.0>8.0

These ranges are guidelines. Individual risk factors and PSA velocity should also be considered.

  • 0 to 2.5 ng/mL: Generally considered low risk for men in their 40s and 50s
  • 2.5 to 4.0 ng/mL: Borderline range that may warrant closer monitoring
  • 4.0 to 10.0 ng/mL: Moderate elevation with about 25% chance of prostate cancer
  • Above 10.0 ng/mL: High elevation with greater than 50% chance of prostate cancer

However, these ranges aren't absolute. Age plays a significant role in what's considered normal. PSA levels naturally increase as men age due to prostate enlargement. A PSA of 2.5 ng/mL might be concerning in a 45-year-old but perfectly normal for a 70-year-old. Understanding your PSA levels requires regular monitoring to track changes over time.

Age-Adjusted PSA Ranges

Many healthcare providers now use age-adjusted PSA ranges to provide more accurate assessments. These ranges recognize that PSA levels naturally increase with age due to benign prostate growth. Using age-specific ranges helps reduce unnecessary biopsies in older men while improving cancer detection in younger men who might have "normal" PSA levels that are actually elevated for their age group.

The Benefits of Low PSA Levels

Low PSA levels are generally a positive indicator of prostate health. Men with PSA levels below 2.5 ng/mL have a significantly lower risk of developing prostate cancer compared to those with higher levels. Studies have shown that men with PSA levels below 1.0 ng/mL have less than a 1% chance of having prostate cancer detected on biopsy.

Beyond cancer risk, low PSA levels often correlate with overall prostate health. Men with low PSA are less likely to experience urinary symptoms associated with prostate enlargement, such as frequent urination, weak urine stream, or difficulty starting urination. This can translate to better quality of life and fewer prostate-related health concerns as men age.

Reduced Screening Frequency

Another benefit of consistently low PSA levels is the potential for less frequent screening. Some medical guidelines suggest that men with PSA levels below 1.0 ng/mL at age 60 may be able to reduce the frequency of PSA testing, as their lifetime risk of dying from prostate cancer is extremely low. However, this decision should always be made in consultation with a healthcare provider who can consider individual risk factors.

When Low PSA Might Not Tell the Whole Story

While low PSA levels are generally reassuring, they don't guarantee the absence of prostate cancer. Approximately 15% of men with PSA levels below 4.0 ng/mL may still have prostate cancer. More concerning is that some aggressive forms of prostate cancer don't produce much PSA, leading to what's called "PSA-negative" prostate cancer.

Certain factors can also artificially lower PSA levels, potentially masking underlying issues. Medications like finasteride or dutasteride, commonly used to treat hair loss or enlarged prostate, can reduce PSA levels by about 50%. Men taking these medications need their PSA results adjusted accordingly. Obesity has also been associated with lower PSA levels, possibly due to hemodilution from increased blood volume.

The Importance of PSA Velocity

Rather than focusing solely on absolute PSA values, healthcare providers increasingly emphasize PSA velocity—the rate of change in PSA levels over time. A rapid rise in PSA, even within the "normal" range, can be more concerning than a stable but slightly elevated level. For example, a PSA that increases from 0.8 to 2.4 ng/mL in one year warrants investigation despite both values being in the low range.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Factors That Influence PSA Levels

Understanding what can affect PSA levels helps interpret test results more accurately. Various factors can cause temporary PSA elevations that don't indicate cancer or serious prostate problems:

  • Recent ejaculation (can elevate PSA for 24-48 hours)
  • Vigorous exercise, especially cycling
  • Prostate infection or inflammation (prostatitis)
  • Recent prostate biopsy or surgery
  • Urinary tract infections
  • Digital rectal examination (though the effect is minimal)

Conversely, some factors can lower PSA levels besides the medications mentioned earlier. These include certain herbal supplements, extreme weight loss, and some cholesterol-lowering medications. Being aware of these factors helps ensure accurate PSA testing and interpretation.

Optimizing Your Prostate Health Monitoring

Effective prostate health monitoring goes beyond single PSA measurements. Establishing a baseline PSA level and tracking changes over time provides the most valuable information. Most experts recommend that men begin discussing PSA screening with their healthcare provider at age 50, or earlier if they have risk factors such as family history of prostate cancer or African American ancestry.

For comprehensive health monitoring that includes PSA testing, consider regular biomarker testing that tracks multiple health indicators simultaneously. Programs that combine PSA testing with other important markers can provide a more complete picture of your overall health and help identify potential issues early.

Beyond PSA: Additional Prostate Health Markers

While PSA remains the primary blood test for prostate health, researchers have developed additional tests to improve accuracy. The free PSA test measures the percentage of PSA that's not bound to proteins in the blood. A lower percentage of free PSA may indicate a higher risk of prostate cancer. Other advanced tests include the Prostate Health Index (PHI) and the 4Kscore test, which combine multiple biomarkers for more precise risk assessment.

Making Informed Decisions About Your PSA Levels

Low PSA levels are generally a positive sign for prostate health, indicating a lower risk of prostate cancer and other prostate conditions. However, they shouldn't be viewed in isolation. The most effective approach to prostate health involves regular monitoring, understanding your individual risk factors, and maintaining open communication with your healthcare provider.

Remember that PSA testing is just one tool in the prostate health toolkit. Combined with digital rectal examinations, consideration of family history, and awareness of symptoms, PSA testing helps create a comprehensive picture of prostate health. Whether your PSA is low, borderline, or elevated, the key is establishing a monitoring plan appropriate for your age, risk factors, and overall health goals.

References

  1. Thompson, I. M., Pauler, D. K., Goodman, P. J., et al. (2004). Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. New England Journal of Medicine, 350(22), 2239-2246.[Link][PubMed][DOI]
  2. Vickers, A. J., Ulmert, D., Sjoberg, D. D., et al. (2013). Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis. BMJ, 346, f2023.[Link][PubMed][DOI]
  3. Carter, H. B., Albertsen, P. C., Barry, M. J., et al. (2013). Early detection of prostate cancer: AUA Guideline. Journal of Urology, 190(2), 419-426.[Link][PubMed][DOI]
  4. Loeb, S., Bjurlin, M. A., Nicholson, J., et al. (2014). Overdiagnosis and overtreatment of prostate cancer. European Urology, 65(6), 1046-1055.[PubMed][DOI]
  5. Schröder, F. H., Hugosson, J., Carlsson, S., et al. (2012). Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). European Urology, 62(5), 745-752.[PubMed][DOI]
  6. Catalona, W. J., Partin, A. W., Sanda, M. G., et al. (2011). A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. Journal of Urology, 185(5), 1650-1655.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my PSA at home?

You can test your PSA at home with SiPhox Health's Hormone Focus Program, which includes PSA testing along with other key hormone biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home with regular monitoring options.

What is considered a dangerously low PSA level?

There's no such thing as a dangerously low PSA level. PSA can be undetectable (less than 0.1 ng/mL) in healthy men and this is not a cause for concern. Very low PSA levels are generally associated with excellent prostate health and very low cancer risk.

Can PSA levels fluctuate day to day?

Yes, PSA levels can fluctuate by up to 20% from day to day due to normal biological variation. Factors like recent ejaculation, exercise, or minor prostate irritation can cause temporary increases. This is why doctors often repeat elevated PSA tests before recommending further action.

At what age should I start PSA testing?

Most men should discuss PSA testing with their doctor starting at age 50. However, men at higher risk (African American men or those with a family history of prostate cancer) should consider starting at age 40-45. The decision should be individualized based on your risk factors and preferences.

Does diet affect PSA levels?

Yes, diet can influence PSA levels. Foods high in lycopene (like tomatoes), omega-3 fatty acids, and green tea may help maintain healthy PSA levels. Conversely, high-fat diets and excessive dairy consumption have been associated with higher PSA levels in some studies.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details